CDKN2A and alpha thalassemia-X-linked intellectual disability syndrome: Nevertheless, PDCLs preserved the main genomic aberrations found in patient tumors, including histone, ATRX (alpha-thalassemia/mental retardation syndrome X-linked) mutations, and CDKN2A (cyclin-dependent kinase inhibitor 2A) homozygous deletion.